Advanced Medical Solutions Group PLC
Company Profile
Business description
Advanced Medical Solutions Group PLC is engaged in developing, and manufacturing advanced wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The company's segment includes: Surgical; and Woundcare, of which Surgical segment derives maximum revenue.
Contact
Premier Park, 33 Road One
Winsford Industrial Estate
WinsfordCheshireCW7 3RT
GBRT: +44 1606863500
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2026
Employees
1,229
Stocks News & Analysis
stocks
Sales shine but broader macro outlook darkens for this ASX share
stocks
Chart of the Week: US equity market trading at an attractive discount
stocks
Undervalued ASX share retains wide moat rating despite regulatory pressures
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,168.90 | 43.80 | 0.48% |
| CAC 40 | 8,203.24 | 60.63 | -0.73% |
| DAX 40 | 23,712.39 | 368.24 | -1.53% |
| Dow JONES (US) | 47,867.32 | 42.60 | -0.09% |
| FTSE 100 | 10,586.43 | 22.45 | -0.21% |
| HKSE | 25,752.40 | 140.62 | -0.54% |
| NASDAQ | 22,571.03 | 63.97 | -0.28% |
| Nikkei 225 | 55,895.32 | 413.10 | -0.73% |
| NZX 50 Index | 13,273.81 | 19.87 | 0.15% |
| S&P 500 | 6,774.43 | 8.38 | -0.12% |
| S&P/ASX 200 | 8,973.20 | 57.80 | 0.65% |
| SSE Composite Index | 3,966.17 | 28.83 | -0.72% |